Skip to main content
SpringerLink
Log in

Pathophysiological significance of plasma endothelin in peripheral circulatory disturbances

  • Published:
Environmental Health and Preventive Medicine Aims and scope

Abstract

Endothelin (ET) is produced in blood vessels and is a novel potent vasoconstrictor. Although the presence of immunoreactive ET in the circulating blood suggests that ET plays an important role in the regulation of systemic and/or local hemodynamics, the role of circulating ET has not been ascertained using human populations. We examined the values of the ET level and peripheral blood flow, including other biochemical and physiological factors, in 108 healthy adults who participated in annual health examinations of Japanese adults living in a rural community in 1992 and 1993. A small change in ET after the passage of one year showed good reproducibility of the value. ET was positively correlated with diastolic blood pressure (BP) and negatively with finger skin blood flow in healthy adults. Multiple regression analysis demonstreted that the positive relationship between ET and diastolic BP was independent of other health indicators. A detailed examination using optical spectroscopy for elderly institutionalized subjects without any trouble in the activity of daily living revealed a negative correlation of ET with saturated oxygen in blood, tissue hemoglobin volume and local blood flow and a positive one with the local oxygen extraction fraction. The present study indicated that increased ET in the elderly subjects was associated with hypoxia not only in the local finger skin region, but also possibly in the arterial tissue, suggesting that ET is involved in atherosclerosis. The negative correlation between ET and finger skin blood flow seen in the healthy adults may be induced by hypoxia. Although we recognized a positive correlation between ET and BP, the increase in ET seemed to be an outcome of elevation in BP rather than a cause of hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yanagisawa M, Kurihara S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–5.

    Article  PubMed  CAS  Google Scholar 

  2. Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens 1991; 4: 303–8.

    PubMed  CAS  Google Scholar 

  3. Cernacek P, Stewart DJ. Immunoreactive endothelin in human plasma: Marked elevations in patients in cardiogenic shocks. Biochem Biophys Res Commun 1989; 161 : 562–7.

    Article  PubMed  CAS  Google Scholar 

  4. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 1992; 85: 1374–9.

    PubMed  CAS  Google Scholar 

  5. Zamora MR, O’’Brien R, Rutherford RB, Weil JV. Serum endothelin-I concentrations and cold provocation in primary Raynaud’s phenomenon. Lancet 1990; 336: 1144–7.

    Article  PubMed  CAS  Google Scholar 

  6. Kanno K, Hirata Y, Emori T, Ohta K, Shichiri M, Shinohara S, Chida Y, Tomura S, Marumo F. Endothelin and Raynaud’s phenomenon. Am J Med 1991; 90: 130–2.

    Article  PubMed  CAS  Google Scholar 

  7. Takahashi K, Ghatei MA, Lam HC, O’Halloran DJ, Bloom SDR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990; 33: 306–10.

    Article  PubMed  CAS  Google Scholar 

  8. Arendt RM, Wilbert-Lamper U, Heucke L. Increased plasma endothelin in patients with hyperlipoproteinemia and stable or unstable angina [abstract]. Circulation 1990; 82: 4.

    Google Scholar 

  9. Lerman A, Haller JW, Heublein DM, Burnett JC Jr. A role for endothelin as a marker of diffuse atherosclerosis in the human [abstract]. J Am Coll Cardiol 1991; 17: 370A.

    Google Scholar 

  10. Goto K, Yanagisawa M, Kimura S, Masaki T. Cardiovascular effects of endothelin. Jpn Circ J 1992; 56: 162–9.

    PubMed  CAS  Google Scholar 

  11. Okada A, Nakamura H. Some features of peripheral circulatory and nervous functions in workers with hand-held vibratory tools. In: Dupuis H, Christ E, Sandover DJ, Taylor W, Okada A, editors. Handarm Vibration. Sankt Augustin : Hauptverband der Gewerblichen Berufsgenossenschaften, 1992 : 37–60.

    Google Scholar 

  12. Sakai A, Saito T, Azuma K, Yanagidaira Y, Asano K. Measurement of regional tissue hemoglobinoxygen saturation in humans using optical spectroscopy. Ikakikaigaku 1994; 64: 264–9.

    Google Scholar 

  13. Nakamura H, Nakamura H, Nohara S, Okada A. Assessment of peripheral circulatory function in workers exposed to hand-arm vibration using non-invasive monitoring system for skin blood flow. In: Okada A, Taylor W, Dupuis H, editors. Hand-arm Vibration. Kanazawa : Kyoei Press, 1990 : 195–9.

    Google Scholar 

  14. Brian SD, Crossman DC, Buckley TL, William TJ. Endothelin-1: Demonstration of potent effects on the microcirculation of humans and other species. J Cardiovasc Pharmacol 1989; 13 Suppl 5 : 147–9.

    Google Scholar 

  15. Kiowski W, Lüscher TF, Linder L, Buhler FR. Endothelin-1-induced vasoconstriction in humans: Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 1991; 83 : 469–75.

    PubMed  CAS  Google Scholar 

  16. Fyhrquist F, Saijonmaa O, Metsarinne K, Tikkanen I, Rosenlof K, Tikkanen T. Raised plasma endothelin-1 concentration following cold pressor test. Biochem Biophys Res Comm 1990; 169: 217–21.

    Article  PubMed  CAS  Google Scholar 

  17. Lüscher TF. Endothelin. J Cardiovasc Pharmacol 1991; 18 Suppl 10: S15-S22.

    PubMed  Google Scholar 

  18. Bondjers G. Anti-atherosclerotic effects of beta-blockers. Eur Heart J 1994; 15 Suppl C: 8–15.

    PubMed  CAS  Google Scholar 

  19. Crawford DW, Blankenhorn DH. Arterial wall oxygenation, oxyradicals, and atherosclerosis. Atherosclerosis 1991; 89: 97–108.

    Article  PubMed  CAS  Google Scholar 

  20. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993; 92: 99–104.

    Article  PubMed  CAS  Google Scholar 

  21. Naruse M, Kawano M, Hifumi S, Naruse K, Yoshihara I, Oka T, Kato Y, Monzen C, Kurimoto F, Ohsumi K, Hosoda S, Demura H. Plasma immunoreactive endothelin, but not thrombomudulin, is increased in patients with essential hypertension and ischemic heart disease. J Cardiovasc Pharmacol 1991; 17 Suppl: S471-S474.

    Article  PubMed  Google Scholar 

  22. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, Ogura M, Inoue A, Marumo F. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990; 15: 493–6.

    PubMed  CAS  Google Scholar 

  23. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, Takeda T. Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990; 88: 614–8.

    Article  PubMed  CAS  Google Scholar 

  24. Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C, Nunez DJ, Capper SJ, Brown MJ. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: Comparison of levels in patients with essential hypertension and normotensive control subjects. Cli Sci 1990; 78: 261–4.

    CAS  Google Scholar 

  25. Miyauchi T, Yanagisawa M, Suzuki N, Iida K, Sugishita Y, Fujino M, Goto K, Masaki T. Venous plasma concentrations of endothelin in normal and hypertensive subjects. Circulation 1989; 80 Suppl II: 2280.

    Google Scholar 

  26. Goto K, Kasuya Y, Matsuki N, Takuwa Y, Kurihara H, Ishikawa T, Kimura S, Yanisagawa M, Masaki T. Endothelin activates the dehydropyridine-sensitive, voltage-dependent Ca channel in vascular smooth muscle. Proc Natl Acad Sci USA 1989; 157: 977–85.

    Google Scholar 

  27. Van Renterghem C, Vigne P, Barhanin J, Schmid-Alliana A, Frelin C, Ladzunski M. Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem Biophys Res Commun 1989; 161: 1049–55.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Public Health, Kanazawa University School of Medicine, Takaramachi 13-1, 920, Kanazawa, Japan

    Hiroyuki Nakamura, Hirofumi Nagase, Masami Yoshida, Takao Okazawa & Akira Okada

Authors
  1. Hiroyuki Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hirofumi Nagase
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masami Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takao Okazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Akira Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakamura, H., Nagase, H., Yoshida, M. et al. Pathophysiological significance of plasma endothelin in peripheral circulatory disturbances. Environ Health Prev Med 1, 51–55 (1996). https://doi.org/10.1007/BF02931173

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02931173

Key words

Search

Navigation